Post on 05-May-2018
M. Guelfi, A. Pantalone, D. Vanni, M. GB. Guelfi, V. Salini
Clinica Ortopedica e Traumatologica
Scuola di Specializzazione in Ortopedia e Traumatologia
Direttore : Prof. Vincenzo Salini
M. Guelfi, A. Pantalone, D. Vanni, M. GB. Guelfi, V. Salini
M. Guelfi, A. Pantalone, D. Vanni, M. GB. Guelfi, V. Salini
Ligatender in Peroneal and Posterior Tibial
Tendonitis
Matteo Guelfi, MD
My disclosure is in the Final AOFAS
Mobile App.
I have no potential conflicts with this
presentation.
M. Guelfi, A. Pantalone, D. Vanni, M. GB. Guelfi, V. Salini
Non-Insertional Foot & Ankle Tendinitis
• Commons and increasing • Sports related • Acute or Chronic • Multifactorial
M. Guelfi, A. Pantalone, D. Vanni, M. GB. Guelfi, V. Salini
Non-Insertional Foot & Ankle Tendinitis
Intrinsic: Malalignment
Leg length inequality Muscles imbalance
Articolar Laxity Females Weight
Estrinsic: Direct Injuries
Overuse Injuries Shoes
Over or wrong training Terrains
M. Guelfi, A. Pantalone, D. Vanni, M. GB. Guelfi, V. Salini
30 recreational athletes affected by: peroneal and posterior tibial tendonitis
• 22 males, 8 females
• Av. Age 29 (22-36)
• 16 runners, 8 soccer, 2
tennis, 3 skaters, 1 cyclist
• MRI negative for tendon’s
lesion
M. Guelfi, A. Pantalone, D. Vanni, M. GB. Guelfi, V. Salini
GROUP A (15 patients*):
• 40 days conservative treatment
• TENS
• TECAR
• Paracetamol 1000mg if needed
GROUP B (15 patients*):
• The same treatment of GROUP A
• + 1 3.5mg sachet per day of
LIGATENDER*
MICRONUTRIENTS contained every sachet of
LIGATENDER* (3.5mg): 550mg Methylsulfonylmethane
(MSM), 450 mg Ornithine alpha-ketoglutarate (OKG), 400
mg Lysine, 100mg Chondroitin-Sulfate, 100mg
Glucosamine, 60mg Vitamin C, 30mg Vitamin E, 0,225mg Biotin.
*randomly selected
M. Guelfi, A. Pantalone, D. Vanni, M. GB. Guelfi, V. Salini
Group B returned to sport 7 days earlier
RESULTS:
M. Guelfi, A. Pantalone, D. Vanni, M. GB. Guelfi, V. Salini
RESULTS:
M. Guelfi, A. Pantalone, D. Vanni, M. GB. Guelfi, V. Salini
RESULTS:
M. Guelfi, A. Pantalone, D. Vanni, M. GB. Guelfi, V. Salini
Peroneal and posterior tibial tendonitis are a common
pathology in people playing sports recreationally.
Based on the results obtained from the present study,
we can assert that in the treatment of early peroneal
and posterior tibial tendonitis without tendon lesion
appreciable at MRI it is rational to integrate
micronutrients in association to conservative
treatment, because it has been demonstrated to
reduce the pain symptoms and the time necessary to
return to play again.
CONCLUSION:
M. Guelfi, A. Pantalone, D. Vanni, M. GB. Guelfi, V. Salini
REFERENCES:
• Osteoarthritis and nutrition. From nutraceuticals to functional foods: a systematic review of the scientific evidence. Ameye LG et al., Arthritis Res Ther. 2006; 8 (4): R127.
• Bank RA et al., Ann Rheum Dis. 1999; 58 (1): 35-41. • Bisseling RW et al., Br J Sports Med. 2007; in press • Clegg DO et al., N Engl J Med 2006; 354: 795-808 • Cynober L, J Nutr. 2004; 134 (10 Suppl): 2858S-2862S. • Cynober LA, Curr Opin Clin Nutr Metab Care. 1999; 2(1): 33-37. • Fredberg U et al., Scand J Med Sci Sports. 1999; 9(2): 66-73. • Gonzalez Santander R et al., Int J Dev Biol. 1996; Suppl 1: 181S-182S. • Magnuson BA et al., Pharmacokinetics and Distribution of [35S] Methylsulfonylmethane
following Oral Administration to Rats. J Agric Food Chem. 2007; 55 (3): 1033-1038. • McAlindon TE et al., JAMA 2000; 283: 1469-1475. • Mello ML et al., Cell Mol Biol 2003; 49 (4): 579-85. • Pacheco-Alvarez D et al., Arch Med Res.2002; 33 (5): 439-47. • Russell JE et al., J Orthop Res. 1991; 9 (5): 714-9. • Tibesku CO et al., Sportverletz Sportschaden. 2005; 19(2): 63-71. • Wittke R et al., MMW Fortschr Med. 2005; 147(25): 28-9, 31-2.